(3R,4S)-1-(tert-butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid is a chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group on the nitrogen atom and a carboxylic acid functional group. It serves as a key chiral building block in pharmaceutical synthesis. This compound is primarily utilized as a high-value pharmaceutical intermediate. Its defined stereochemistry (3R,4S) and functional groups make it a crucial precursor in the synthesis of complex drug candidates, particularly those targeting the central nervous system (CNS) and other therapeutic areas where the pyrrolidine scaffold is pharmacologically relevant. The Boc group facilitates selective deprotection during multi-step synthetic sequences. As a non-commercial, research-grade chemical, it is handled under standard laboratory safety protocols. Its primary value lies in enabling the construction of stereochemically pure active pharmaceutical ingredients (APIs) and advanced intermediates for drug discovery and development programs.